Cargando…

One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka

Background: Sri Lanka is a low-income country, as defined by the World Bank. The country suffered further economic downturn during the COVID-19 pandemic. This situation adversely affected the prioritization of policies and programs around healthcare and public health. In particular, inflation, fuel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ariyawansa, Sujeewa, Gunawardana, Kuruwitage N., Hapudeniya, Muditha M., Manelgamage, Nimal J., Karunarathne, Chinthana R., Madalagama, Roshan P., Ubeyratne, Kamalika H., Wickramasinghe, Darshana, Tun, Hein M., Wu, Peng, Lam, Tommy T. Y., Chan, Olivia S. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044479/
https://www.ncbi.nlm.nih.gov/pubmed/36978313
http://dx.doi.org/10.3390/antibiotics12030446
_version_ 1784913362323243008
author Ariyawansa, Sujeewa
Gunawardana, Kuruwitage N.
Hapudeniya, Muditha M.
Manelgamage, Nimal J.
Karunarathne, Chinthana R.
Madalagama, Roshan P.
Ubeyratne, Kamalika H.
Wickramasinghe, Darshana
Tun, Hein M.
Wu, Peng
Lam, Tommy T. Y.
Chan, Olivia S. K.
author_facet Ariyawansa, Sujeewa
Gunawardana, Kuruwitage N.
Hapudeniya, Muditha M.
Manelgamage, Nimal J.
Karunarathne, Chinthana R.
Madalagama, Roshan P.
Ubeyratne, Kamalika H.
Wickramasinghe, Darshana
Tun, Hein M.
Wu, Peng
Lam, Tommy T. Y.
Chan, Olivia S. K.
author_sort Ariyawansa, Sujeewa
collection PubMed
description Background: Sri Lanka is a low-income country, as defined by the World Bank. The country suffered further economic downturn during the COVID-19 pandemic. This situation adversely affected the prioritization of policies and programs around healthcare and public health. In particular, inflation, fuel prices, and shortage of food supplies increased struggles to implement antimicrobial resistance (AMR) programs. However, in the long run, it is crucial to gather data and evidence to plan AMR policies and track interventions. (1) Aim: To establish and reiterate the importance of prioritizing AMR programs in the One Health framework, the Fleming Fellows collected and studied antimicrobial use/consumption (AMU/AMC) and resistance (AMR) in humans, food-producing animals, and the environment. (2) Methods: A systematic and cross-sectional study was conducted between 2019 and 2021. By way of coordinating an AMU/AMC and AMR prevalence study across six agencies from human health and food-producing animal sectors, the authors established a field epidemiology study, laboratory testing, and data processing at their institutions. AMU/AMC patterns were surveyed using questionnaires and interviews, while AMR samples were collected for antibiotic susceptibility tests and genomic tests. Samples were tested for phenotypic and genotypic resistance. (3) Results: In human samples, resistance was highest to beta-lactam antibiotics. In non-human samples, resistance was highest to erythromycin, a highest-priority, critically important antibiotic defined by the World Health Organization. From government records, tylosin was sold the most in the food-producing animal sector. (4) Conclusions: Sri Lanka AMU and AMR trends in human and non-human sectors can be ascertained by a One Health framework. Further coordinated, consistent, and sustainable planning is feasible, and can help implement an AMU/AMR surveillance system in Sri Lanka.
format Online
Article
Text
id pubmed-10044479
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100444792023-03-29 One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka Ariyawansa, Sujeewa Gunawardana, Kuruwitage N. Hapudeniya, Muditha M. Manelgamage, Nimal J. Karunarathne, Chinthana R. Madalagama, Roshan P. Ubeyratne, Kamalika H. Wickramasinghe, Darshana Tun, Hein M. Wu, Peng Lam, Tommy T. Y. Chan, Olivia S. K. Antibiotics (Basel) Article Background: Sri Lanka is a low-income country, as defined by the World Bank. The country suffered further economic downturn during the COVID-19 pandemic. This situation adversely affected the prioritization of policies and programs around healthcare and public health. In particular, inflation, fuel prices, and shortage of food supplies increased struggles to implement antimicrobial resistance (AMR) programs. However, in the long run, it is crucial to gather data and evidence to plan AMR policies and track interventions. (1) Aim: To establish and reiterate the importance of prioritizing AMR programs in the One Health framework, the Fleming Fellows collected and studied antimicrobial use/consumption (AMU/AMC) and resistance (AMR) in humans, food-producing animals, and the environment. (2) Methods: A systematic and cross-sectional study was conducted between 2019 and 2021. By way of coordinating an AMU/AMC and AMR prevalence study across six agencies from human health and food-producing animal sectors, the authors established a field epidemiology study, laboratory testing, and data processing at their institutions. AMU/AMC patterns were surveyed using questionnaires and interviews, while AMR samples were collected for antibiotic susceptibility tests and genomic tests. Samples were tested for phenotypic and genotypic resistance. (3) Results: In human samples, resistance was highest to beta-lactam antibiotics. In non-human samples, resistance was highest to erythromycin, a highest-priority, critically important antibiotic defined by the World Health Organization. From government records, tylosin was sold the most in the food-producing animal sector. (4) Conclusions: Sri Lanka AMU and AMR trends in human and non-human sectors can be ascertained by a One Health framework. Further coordinated, consistent, and sustainable planning is feasible, and can help implement an AMU/AMR surveillance system in Sri Lanka. MDPI 2023-02-23 /pmc/articles/PMC10044479/ /pubmed/36978313 http://dx.doi.org/10.3390/antibiotics12030446 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ariyawansa, Sujeewa
Gunawardana, Kuruwitage N.
Hapudeniya, Muditha M.
Manelgamage, Nimal J.
Karunarathne, Chinthana R.
Madalagama, Roshan P.
Ubeyratne, Kamalika H.
Wickramasinghe, Darshana
Tun, Hein M.
Wu, Peng
Lam, Tommy T. Y.
Chan, Olivia S. K.
One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka
title One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka
title_full One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka
title_fullStr One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka
title_full_unstemmed One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka
title_short One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka
title_sort one health surveillance of antimicrobial use and resistance: challenges and successes of implementing surveillance programs in sri lanka
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044479/
https://www.ncbi.nlm.nih.gov/pubmed/36978313
http://dx.doi.org/10.3390/antibiotics12030446
work_keys_str_mv AT ariyawansasujeewa onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT gunawardanakuruwitagen onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT hapudeniyamuditham onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT manelgamagenimalj onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT karunarathnechinthanar onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT madalagamaroshanp onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT ubeyratnekamalikah onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT wickramasinghedarshana onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT tunheinm onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT wupeng onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT lamtommyty onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka
AT chanoliviask onehealthsurveillanceofantimicrobialuseandresistancechallengesandsuccessesofimplementingsurveillanceprogramsinsrilanka